Research and Development: A Critical Driver of Universal Health Coverage
Examine how R&D of new drugs, vaccines, diagnostics, and other tools is a critical driver of universal health coverage.
Examine how R&D of new drugs, vaccines, diagnostics, and other tools is a critical driver of universal health coverage.
Illustrates how and how much the World Health Organization is investing across its R&D programs and how they are financed.
Calls on G20 Heads of Government and Ministers to elevate health on the G20 agenda and prioritize investments in health innovation to deliver on the vision of health for all. The report looks at concrete examples of successful models, partnerships, mechanisms, and financing approaches that have accelerated the development and scale-up of global health technologies and system innovations, and provides recommendations to G20 policymakers that if implemented would increase momentum in global health innovation and strengthen the health and economies of all nations, whether high-, middle-, or low-income.
Provides analysis of the World Health Organization’s (WHO) draft Road Map for Access to Medicines, Vaccines and Other Health Products including an overview of the contents and the potential implications if approved. This roadmap, which outlines WHO’s proposed workplan on access for the period 2019–2023, will be presented to the WHO Executive Board in January 2018 for input and then will go before the World Health Assembly in May for endorsement.
Find out about GHTC’s membership options and the benefits of becoming a member.
Learn MoreWe bring together nonprofits, academic institutions, and aligned businesses that are committed to advancing health equity through innovation.